Latest News
Tuesday December 30, 2008 — Immucor, Inc.
NORCROSS, Ga., Dec. 29 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its fiscal second quarter earnings on Wednesday, January 7, 2009, after the close of reg...
Thursday October 2, 2008 — Immucor, Inc.
NORCROSS, Ga., Oct. 1 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal first quarter ended August 31, 2008. Our first quarter 2009 results include the resu...
Thursday September 25, 2008 — Immucor, Inc.
NORCROSS, Ga., Sept. 24 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its first quarter earnings on Wednesday, October 1, 2008, after the close of regular tr...
Wednesday August 6, 2008 — Immucor, Inc.
NORCROSS, Ga., Aug. 5 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has closed its previously-announced acquisition of BioArray Solutions Ltd.Gioacchino De Chirico, President ...
Saturday August 2, 2008 — Zacks.com: Analyst Blog
Immucor, Inc. (BLUD) continues to progress in the development of another version of the Galileo. The company's strong earnings growth has been driven by double-digit sales escalation, gross margin expansion, and operating cost control. The additional worldwide placements of Galileo contin...
Saturday July 26, 2008 — Immucor, Inc.
NORCROSS, GA., July 25 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Dr. Paul V. Holland, James F. Clouser and Chris E. Perkins have agreed to join Immucor's Board of Directors ef...
Thursday July 24, 2008 — Immucor, Inc.
NORCROSS, Ga., July 23 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal fourth quarter and year ended May 31, 2008."We are very pleased with our fiscal 200...
Thursday July 17, 2008 — Immucor, Inc.
NORCROSS, Ga., July 16 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its fourth quarter and year end earnings on Wednesday, July 23, 2008, after the close of...
Wednesday July 2, 2008 — Zacks.com: Analyst Blog
A number of positive trends and developments make us optimistic about blood-testing products maker Immucor, Inc.'s (BLUD) growth. Gross margins are expected to regain momentum from the eventual growth in reagent sales, manufacturing efficiencies, and price increases.
The additional worl...
Saturday June 7, 2008 — Immucor, Inc.
NORCROSS, Ga., June 6 /PRNewswire-FirstCall/ -- Immucor, Inc., , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced that today the FDA notified the company that it has reviewed Immucor's response to the previously-reported warning letter...
Thursday June 5, 2008 — Immucor, Inc.
NORCROSS, Ga., June 4 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced revenue and earnings guidance for the fiscal year ending May 31, 2009. For fiscal year 2009:
-- The company expe...
Thursday May 29, 2008 — Immucor, Inc.
NORCROSS, Ga., May 28 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced it expects to release its fiscal 2009 guidance on Wednesday, June 4, 2008, after the close of regular trading hours,...
Tuesday May 13, 2008 — Immucor, Inc.
NORCROSS, Ga., May 13 /PRNewswire-FirstCall/ -- Immucor, Inc., , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today it is responding to an FDA warning letter posted today on the FDA website (http://www.fda.gov/foi/warning.htm).Immu...
Friday April 18, 2008 — Immucor, Inc.
NORCROSS, Ga., April 17 /PRNewswire-FirstCall/ -- Immucor, Inc., , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today the first level of the Italian court case against CEO Gioacchino "Nino" De Chirico has concluded and will now mov...
Monday April 14, 2008 — Zacks.com: Analyst Blog
Immucor, Inc. (BLUD) reported Q3 EPS that beat our estimate by $0.04 on revenue that also exceeded our forecast. Management expects revenue, gross margin, and EPS to be at the high end or modestly higher from the guidance that was previously announced on May 31, 2007. The pending acquisit...
Thursday April 3, 2008 — SchaeffersResearch
It was a very good day for Immucor (BLUD). After the close on Tuesday, the blood transfusion systems reported its third-quarter net income rose to $19.3 million, or 27 cents per share, from its year-ago earnings of $15 million, or 21 cents a share. Revenue jumped 17.3% to $67 million. Meanwhile...
Wednesday April 2, 2008 — Immucor, Inc.
NORCROSS, Ga., April 1, 2008 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal third quarter ended February 29, 2008.Revenue for the fiscal third quarter wa...
Friday March 28, 2008 — Immucor, Inc.
NORCROSS, Ga., March 27 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its third quarter earnings on Tuesday, April 1, 2008, after the close of regular tradin...
Wednesday March 12, 2008 — Immucor, Inc.
NORCROSS, Ga., March 11 /PRNewswire-FirstCall/ -- Immucor, Inc., a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that it has signed a definitive agreement to acquire BioArray Solutions Ltd., a privately held company based in War...
Wednesday January 30, 2008 — Immucor, Inc.
NORCROSS, Ga., Jan. 29 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, announced today that Ronny B. Lancaster has agreed to join Immucor's Board of Directors effective February 1, 2008. Mr. Lancaster ...
Friday January 18, 2008 — Zacks.com: Analyst Blog
Blood-testing product developer Immucor, Inc. (BLUD) has recently been upgraded to a Buy as a pull-back in the stock helped its valuation become more attractive. Zacks senior medical devices industry analyst Tom Park had these comments in his latest report on the company: 'BLUD reported Q...
Tuesday January 8, 2008 — Immucor, Inc.
NORCROSS, Ga., Jan. 7 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for the fiscal second quarter ended November 30, 2007.Revenue for the fiscal second quarter was $61...
Monday January 7, 2008 — Immucor, Inc.
NORCROSS, Ga., Jan. 7 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced an update to the telephone conference call number for its second quarter earnings call to be held on Tuesday, Januar...
Monday January 7, 2008 — StockWeb
MondayEconomic: NAEarnings: Schnitzer (SCHN), Immucor (BLUD)TuesdayEconomic: Pending Home Sales (-.5%)Earnings: Acuity (AYI), Constellation Brands (STZ), KB Home (KBH), RPM (RPM), Oxford (OXM), Xyratex (XRTX), Apollo (APOL)WednesdayEconomic: NAEarnings: Mosaic (MOS), Alcoa (AA)ThursdayEconomic: We...
Wednesday January 2, 2008 — Immucor, Inc.
NORCROSS, Ga., Jan. 2 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that it expects to release its second quarter earnings on Monday, January 7, 2008, after the close of regular tradin...